The Glucocorticoid Receptor: Isoforms, Functions, and Contribution to Glucocorticoid Sensitivity
Open accessThe DOI matches its Crossref record; 429 of the 437 references it cites were found in a registry or an index.
Abstract
Glucocorticoids exert pleiotropic effects on all tissues to regulate cellular and metabolic homeostasis. Synthetic forms are used therapeutically in a wide range of conditions for their anti-inflammatory benefits, at the cost of dose and duration-dependent side effects. Significant variability occurs between tissues, disease states, and individuals with regard to both the beneficial and deleterious effects. The glucocorticoid receptor (GR) is the site of action for these hormones and a vast body of work has been conducted understanding its function. Traditionally, it was thought that the anti-inflammatory benefits of glucocorticoids were mediated by transrepression of pro-inflammatory transcription factors, while the adverse metabolic effects resulted from direct transactivation. This canonical understanding of the GR function has been brought into question over the past 2 decades with advances in the resolution of scientific techniques, and the discovery of multiple isoforms of the receptor present in most tissues. Here we review the structure and function of the GR, the nature of the receptor isoforms, and the contribution of the receptor to glucocorticoid sensitivity, or resistance in health and disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 2. Mechanisms of glucocorticoid receptor (GR) action. GR is maintained in the cytoplasm by an anchoring complex [1] which modifies the conformation of GR to allow high affinity for glucocorticoids [2]. Glucocorticoids cross the membrane where they can be activated/inactivated by 11β-ΗSD isoforms [3]. Binding of active glucocorticoid to GR leads to dissociation of the complex [4]. GR can have a series of nongenomic effects in the cytoplasm (see text for details), or predominantly enters the nucleus. GR binds to open chromatin (determined by pioneering transcription factors) [5] where it can: directly activate or repress transcription at canonical GREs, direction of regulation determined by cofactors, gene, other transcription factors [6]; repress transcription at nGREs [7]; interact with other transcription factors either as a monomer or dimer at shared binding sites to enhance/repress transcription [8, 9], whether this can occur without direct DNA binding (tethering) [8] has been brought into question; or compete for binding sites with other transcription factors [10]. Unliganded GR is bound throughout open chromatin [11] and dissociates in favor of glucocorticoid-bound dimers upon exposure. Created with Biorender.com.](https://figures.cochat.ai/paper-figures/3bbfa8b9567944a7a9295cc44a92c926/the-glucocorticoid-receptor-isoforms-functions-and-contribution-to-figure-2.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“It maintains homeostasis and exerts anti-inflammatory actions, such as regulating leukocyte trafficking and reducing pro-inflammatory cytokine secretion, via these pathways [7,8].”
From Chronic Stress and Autoimmunity: The Role of HPA Axis and Cortisol Dysregulation (2025) · cites this paper as [8]
The cited source says what the claim attributes to it.
In the citing paper
“A higher level of glucocorticoids tends to activate GRs, promoting the expression of a diverse range of genes. This mechanism is believed to mediate the effects of glucocorticoids on inflammatory responses and neuronal functions [48].”
From Chronic Stress-Associated Depressive Disorders: The Impact of HPA Axis Dysregulation and Neuroinflammation on the Hippocampus—A Mini Review (2025) · cites this paper as [48]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Stress and disorders of the stress system
Chrousos, G. P. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.106 · Cited by 3,215
Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress
Tsigos, C., & Chrousos, G. P. (2002) · Journal of Psychosomatic Research · doi:10.1016/s0022-3999(02)00429-4 · Cited by 2,822
The Hypothalamic–Pituitary–Adrenal Axis and Immune-Mediated Inflammation
Chrousos, G. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322008 · Cited by 2,579
Nuclear Receptor Coregulators: Cellular and Molecular Biology*
McKenna, N. J., Lanz, R. B., & O’Malley, B. W. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.3.0366 · Cited by 1,911
Kirschbaum, C., Kudielka, B. M., Gaab, J., Schommer, N. C., & Hellhammer, D. H. (1999) · Psychosomatic Medicine · doi:10.1097/00006842-199903000-00006 · Cited by 1,890
Primary structure and expression of a functional human glucocorticoid receptor cDNA
Hollenberg, S. M., Weinberger, C., Ong, E. S., Cerelli, G., Oro, A., Lebo, R., Brad Thompson, E., Rosenfeld, M. G., & Evans, R. M. (1985) · Nature · doi:10.1038/318635a0 · Cited by 1,869
Resetting of circadian time in peripheral tissues by glucocorticoid signaling
Balsalobre, A., Brown, S. A., Marcacci, L., Tronche, F., Kellendonk, C., Reichardt, H. M., Schütz, G., & Schibler, U. (2000) · Science · doi:10.1126/science.289.5488.2344 · Cited by 1,859
Coutinho, A. E., & Chapman, K. E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.04.005 · Cited by 1,815
Steroid Receptor Interactions with Heat Shock Protein and Immunophilin Chaperones*
Pratt, W. B., & Toft, D. O. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0303 · Cited by 1,791
Cited by
Items 101–168 of 168
Study of Functional Food Factors Maintaining the Quality of Skeletal Muscle
Yoshioka, Y. (2026) · Nippon Eiyo Shokuryo Gakkaishi · doi:10.4327/jsnfs.79.41
Wu, H., Lan, Z., Zhang, T., Dai, W., Zhang, J., Chen, X., Li, S., Huang, M., Xue, S., & Liao, J. (2026) · Research Square · doi:10.21203/rs.3.rs-8917613/v1
Esteban-Pérez, N., Sol‐Fernández, S. D., Martín‐Rapún, R., & de la Fuente, J. M. (2026) · Nanoscale Horizons · doi:10.1039/d5nh00782h
Sakagami, H., Acra, A. M., Harada, T., Iwasa, F., ABE, M., Inomata, M., Aoyagi, H., Tsukahara, T., Bandow, K., KADOKURA, H., et al. (2026) · Medicines · doi:10.3390/medicines13020012
“Glucocorticoids act on almost all cells, but responses vary significantly between cell types due to factors such as transcription factor networks, chromatin state [19], and changes in GR α /GR β isoforms [20].”
Zhu, L., Huang, Y., Peng, B., Zhong, S., Zhang, X., Xiao, F., Asim, D., Pakezhati, J., Ma, J., Sun, S., et al. (2026) · Cellular and Molecular Immunology · doi:10.1038/s41423-026-01407-w
Haack, M., Chan, J. G. M., Engert, L. C., Dang, R., Wang, H., Borducchi, E. N., Shah, K., Liu, J., Sun, H., Ganglberger, W., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-47039-y
“Several factors can modulate GC sensitivity 51 .”
Potential mechanisms of the glucocorticoid withdrawal syndrome
Snyder, C. N., Frontera, E. D., Meng, J., Wallace, B. I., & Spencer-Segal, J. L. (2026) · European Journal of Endocrinology · doi:10.1093/ejendo/lvag062
Kong, X., Wang, P., Zhang, S., Kou, L., Tan, M., Xie, Z., & Guo, W. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05379-6
“Glucocorticoids are one of the most potent classes of anti-inflammatory agents, mediating their pharmacological actions primarily via activation of the glucocorticoid receptor (GR) (Cain and Cidlowski 2017; Lockett et al. 2024).”
Recent insights into the protective effects of lactic acid bacteria on rheumatoid arthritis
Chen, Y., Long, B., Li, X., Lan, Y., Mu, Y., Wang, C. R., Xia, L., Wang, Q., Gao, J., Peng, M., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108222
Repercussões clínicas da automedicação com corticoides para fins estéticos e esportivos
Dávila, R. A., & Ohara, G. H. (2026) · International Journal of Health and Surgical Research · doi:10.5281/zenodo.20173325
Xu, Q.-Y., Zhang, J., Wan, X., Ling, W., Yang, J.-C., & Yan, L. (2026) · Military Medical Research · doi:10.1016/j.mmr.2026.100037
“At the receptor level, an elevated GR /GR ratio serves as a key biomarker for clinical insensitivity, as GR competitively inhibits active GC signaling [176].”
Li, Q., Chen, X., Huang, Z., Zhang, Y., Kuang, Y., Wu, C., Fu, S., Wang, T., Liu, Y., Huang, Z., et al. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1769220
Steroids in organ transplantation: Immunosuppression and tolerance
Jyoti, Singh, G., Bishnoi, M., Kaur, R., Sethi, S. K., Hemlata, Paliwal, D., Minhas, R., Akash, M. B., & Gulati, H. K. (2026) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2026.107039
Monika, R., & Sampathkumar, P. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.41s.105
Milanović, D., Lushchaeva, T., Ha, H. M., Covrig, R.-C., Scheller, C., Stein, K.-P., Sandalcioglu, I. E., Wiede, A., Glowka, A., & Medenwald, D. (2026) · Radiation · doi:10.3390/radiation6020019
“Both bind to the glucocorticoid receptor in the cell nucleus, where they influence the expression of certain genes involved in the anti-inflammatory response [33].”
Abid, A., & Shabbir, M. A. (2026) · Archives of Medical Research · doi:10.1016/j.arcmed.2026.103450
Oakley, R. H., Sueyoshi, T., Ramamoorthy, S., Nikolova, V. D., Goulding, D. R., LI, J., Ray, M. K., Moy, S. S., & Cidlowski, J. A. (2026) · The FASEB Journal · doi:10.1096/fj.202601316r
“The single GR gene ( Nr3c1 ) gives rise to the classic full-length receptor (GR-A) and 7 additional isoforms with progressively shorter NTDs (GR-B, GR-C1, GR-C2, GR-C3, GR-D1, GR-D2, and GR-D3) via highly conserved alternative translation initiation sites (Figure 1A) [1, 5–7].”
Siam, S., Boeckel, G. R., Hasan, C., Pavenstädt, H., Budde, K., & Reuter, S. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1867698
“Glucocorticoids exert their canonical immunosuppressive effects through the cytosolic glucocorticoid receptor (GR), a ligand-activated transcription factor (24, 25).”
Ye, B., Yao, J., Wang, Y., Liao, X., Wu, D., Wang, M. X., Fang, X., Gao, J., Li, Q., & Gao, W. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08415-4
“Most critically, this microenvironment induces epigenetic alterations, primarily by reducing HDAC2 activity/ expression via oxidative stress and cytokine signaling, crippling the GR’s anti-inflammatory transcriptional efficacy and cementing resistance [58] (Table 1).”
Innovations in glucocorticoid therapy: from systemic action to precision medicine
Pugaci, F., & Pogonea, I. (2026) · Medic ro · doi:10.26416/med.171.3.2026.11569
How post-translational modifications impact glucocorticoid receptor function in human pathologies
Bouveret, Z., Pruvost, L., Trédan, O., Romancer, M. L., & Poulard, C. (2026) · Cell Communication and Signaling · doi:10.1186/s12964-026-03015-7
“Alternative splicing generates several GR isoforms, including GRα and GRβ, which are the predominant variants [4].”
Pereira, T. C., Rocha, L., & Faria, R. X. (2026) · Journal of Immunology Research · doi:10.1155/jimr/7715676
Shi, H., Guan, Q., Wang, Z., Cao, J., Dong, Y., & Chen, Y. (2026) · Antioxidants · doi:10.3390/antiox15070800
“Specifically, we hypothesise that the spleen responds to aberrant CORT signals via its highly expressed glucocorticoid receptor (GR), accompanied by changes in GR expression, NF-κ B-related inflammatory signalling, and Nrf2/HO-1-associated antioxidant responses [25,26].”
Sharif‐Askari, N. S., Al-Sheakly, B. K. S., Mdkhana, B., Shakartalla, S. B., Eladham, M. W., Almoalla, A. A., Hmoudi, M. A. S. M. A., Alhmoudi, A. M. S. A., Sharif‐Askari, F. S., Tsombou, F. M., et al. (2026) · Fitoterapia · doi:10.1016/j.fitote.2026.107368
Horvat, N. (2026) · Repository of the University of Ljubljana (University of Ljubljana)
Martinez, G. J., Kipp, Z. A., Bates, E. A., Pauss, S. N., Marino, J. S., & Hinds, T. D. (2026) · Livers · doi:10.3390/livers6040064
“The findings in this manuscript corroborate GR β ’s regulation of inflammatory pathways [63], as noted by analysis of RNAseq data using GO Biological functions.”
Der Einfluss des rs6198-Polymorphismus im Glucocorticoidrezeptor-Gen auf das Überleben bei Sepsis
Sombetzki, C. (2026) · Dokumentenrepositorium der RUB (Ruhr University Bochum) · doi:10.13154/294-14568
Jackson, T. W., Alewel, D. I., Vance, S. A., Gavett, S. H., Schladweiler, M. C. J., Evansky, P., Monsees, M., Freeborn, D. L., Martin, J., George, I. J., et al. (2026) · Inhalation Toxicology · doi:10.1080/08958378.2026.2697433
“Because glucocorticoids transcriptionally regulate nearly 20% of human genome (Lockett et al. 2024) with tissue-specific regulation, which then mediatehomeostatic functional physiological processes (Lockett et al. 2024), changes in lung transcriptional activity may underlie lung-specific functional…”
Hong, S., Han, Y., Wang, H., Fan, X., Liu, W., Qiao, L., Jiang, L., & Liu, J. (2026) · Steroids · doi:10.1016/j.steroids.2026.109836
Signal Transduction and Drugs that Target Signaling Pathways
Minden, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-20529-2_18
Ma, M., Li, G., Qin, X., Zhang, G., Shen, C., Guo, Z., Li, X., Zheng, Y., Wang, S., Pan, B., et al. (2026) · Pharmaceuticals · doi:10.3390/ph19081211
“Cort exerts its biological effects primarily through binding to GR. Ligand binding triggers a conformational change in GR, leading to its nuclear translocation, where it regulates transcription of downstream target genes [21,22].”
Long, R., Li, Y., Gong, X., Wu, R., Yang, Q., Wang, D., Yang, Y., & Chen, N. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1861198
“Second, although not directly assessed in our patients, differences in tissue glucocorticoid sensitivity — potentially related to glucocorticoid receptor polymorphisms or local regulation by 11 b -hydroxysteroid dehydrogenase enzymes — may also contribute to this discordance (18, 19).”
Blin, J., Moullé, V. S., Garel, Z., Bertholon, U., Oullier, T., Durand, T., Berre‐Scoul, C. L., Masson, D., Bach‐Ngohou, K., & Neunlist, M. (2026) · iScience · doi:10.1016/j.isci.2026.116993
“…the GC receptor (GR), which is ubiquitously expressed and regulates the transcription of numerous genes involved in a wide range of physiological processes, including energy metabolism and inflammation, 3 as well as cell-specific functions such as epithelial repair and neuronal connectivity.”
Wang, X., Tang, J., Yang, L., Zhang, F., Shen, Z., Duan, Y., Li, Y., Ge, Y., Li, J., Zhang, Y., et al. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.112275
Epigenomic patterns in fish with divergent cortisol reactivity
Chehida, S. B., Σαμαράς, Α., Krick, M., Dimitroglou, A., Desmarais, É., Papaharisis, L., Pavlidis, M. A., Tsigenopoulos, C. S., & Guinand, B. (2026) · Physiological Genomics · doi:10.1152/physiolgenomics.00298.2025
Bennett, M. P., Meakin, A. S., Botting, K. J., Niu, Y., Ford, S. G., Wiese, M. D., Giussani, D. A., & Morrison, J. L. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108379
Guo, Z., Lyons, S. A., & Beaudry, J. L. (2026) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2026.07.013
Ma, X., Zhang, Y., Xu, M., Dong, Y., & Tang, X. (2026) · ChemistrySelect · doi:10.1002/slct.74247
Drug Resistance in Multiple Myeloma: Tumor‐Intrinsic Mechanisms and the Bone Marrow Microenvironment
Chen, Y., Huang, W., Tang, M., & Wang, X. (2026) · Cell Biochemistry and Function · doi:10.1002/cbf.70286
“In GC‐sensitive MM cell lines, GR‐α predominates and declines with stepwise resistance, while late‐stage resistant lines may shift toward dominant GR‐β [72].”
Meduri, G. U., & Torres, A. (2026) · Medical Sciences · doi:10.3390/medsci14060638
“The biological and mechanistic properties that collectively support the proposed role of GC–GR α as a central integrative regulator of organism-wide homeostatic correction are summarized in Table 1 [3,33,66,69,74–79].”
Extending the reach of transcription factors to mRNA stability
Galvan, B., Ongena, L., Claes, M., Mariavelle, E., & Dequiedt, F. (2026) · Trends Open · doi:10.1016/j.treopn.2026.07.017
Wang, Z., 谭支内, Zhang, Y., Li, Y., Lin, J., Xu, Y., Li, Y., & Chen, T. (2026) · Acta Neurologica Belgica · doi:10.1007/s13760-026-03168-9
Biddle, M., Cooper, J., Jones, C., Dixon, K., & Virk, H. S. (2026) · F1000Research · doi:10.12688/f1000research.187961.1
Li, Y.-J., Jiang, W., Zhang, C., Rommer, P. S., Levy, M., Paul, F., & Shi, F. (2026) · Cell Death and Differentiation · doi:10.1038/s41418-026-01863-x
Liu, F., Li, Y., Wang, Q., Liu, Y., Li, G., Song, J., Liu, L., Wang, J., Yang, S., Xiao, J., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-71069-1
Pais, M. (2026) · Radboud University Press eBooks · doi:10.54195/9789465153001
Sali, E., Paschou, I. A., Dimopoulou, S. M., Tagka, A., Chasapi, V., Nicolaidou, E., Stratigos, A. J., Peppa, Μ., & Paschou, S. Α. (2026) · Endocrine · doi:10.1007/s12020-026-04778-2
“Glucocorticoids (GCs) are synthetic analogues of the endogenous hormones produced by the adrenal cortex under the hypothalamic–pituitary–adrenal (HPA) axis control [1].”
InfluentialSchneider, J. (2026) · Gutenberg Open Science · doi:10.25358/openscience-16388
Wijsman, T., Wittmer, J., Winter, R., Bruins, T., van Zeijl, A., Nijveen, H., Scheres, B., & Heidstra, R. (2026) · The Plant Journal · doi:10.1111/tpj.71151
“When the ligand is bound, the steroid receptor domain undergoes a conformational change (Lockett et al., 2024; Yas (cid:1) ar et al., 2017), thereby activating the STF to drive transcription from the synthetic promoter.”
Guangduo, H. A. N., Xinlong, L. I., Zhuang, F., Liu, S., Wentao, Z. H. U., Wei, F. A. N. G., 童加冰, & Wang, D. (2026) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2026.122438
Interplay between the glucocorticoid and androgen receptors in prostate cancer cells
Helminen, L. (2026) · UEF eRepo (University of Eastern Finland)
Abbasi, A. A., & Moradikor, N. (2026) · Pharmacotherapy in Psychiatry and Neurology · doi:10.17219/fpn/240586
Architect or Destroyer: The Diversity of Glucocorticoid Receptor Signaling Pathways in the Brain
Shkarina, L. N., Khaybullina, R., Primak, A. L., Дмитриевич, Б. К., Станиславович, Д. С., & Karagyaur, M. N. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27209027
“…of coregulators and of chromatin-modifying enzymes depends, since these use acetyl-CoA, NAD+, S-adenosylmethionine, and ATP as substrates and cofactors [54,55]; by post-translational modifications and conformational changes in GR and of its partners [56]; and also by the state of chromatin [57,58].”
Dexamethasone-mediated modulation of the renin-angiotensin system: current insights
Gajewska, K., Wosiak, A., Wiertek-Płoszaj, N., Broszkiewicz, W., & Domińska, K. (2026) · Pharmacological Reports · doi:10.1007/s43440-026-00915-w
Slayden, R. A., Tjalkens, R. B., Theise, N. D., Verrico, C. D., Azevedo, E. P., Drie, J. H. V., Bardo, M. T., Prendergast, M., Butt, C. M., Altschul, R., et al. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1931270
Steroid Hormone Receptors and Signal Transduction Processes
Klinge, C. M. (2026) · Endocrinology · doi:10.1007/978-3-319-27318-1_9-2
Pathogenesis of steroid refractoriness in acute graft versus host disease
Debes, M. S., Ali, S. M., Abouzeid, M., Aljrad, M., & Elyasaky, A. (2026) · Molecular Biology Reports · doi:10.1007/s11033-026-12935-z
Stiller, T., Busch, R., Faudone, G., Haffelder, F. C., Vietor, J., Kardanov, A., López-García, Ú., Hackspacher, A., Höfner, G. C., Morozov, V., et al. (2026) · Angewandte Chemie Novit · doi:10.1002/anov.70039
Ma, S., Liu, M., Ge, C., Zheng, Y., Wang, S., Gao, T., Shi, Y., Sun, Y., Xu, Z., Wang, X., et al. (2026) · Scientific Reports · doi:10.1038/s41598-026-76626-2
Zhang, R., Zhang, X., He, X., & Xiang, M. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1983756
Guo, J., Feng, Q., Shen, K., Cheng, J., Zhu, Y., Luan, Y., Gao, J., Zhu, S., Huang, F., Zhang, N., et al. (2026) · Molecules · doi:10.3390/molecules31213917
Bronkhorst, H., Schrauwen, T., Wijnants, A., Escobar, N., Kloet, S. L., Meijer, A. H., Schaaf, M., & Faught, E. L. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.26.761887
Chen, Z.-X., Sa, R., Wen, Z., Ma, R., & Tong, L.-J. (2026) · World Journal of Psychiatry · doi:10.5498/wjp.125825
CYP-mediated drug metabolism from fetal life to adulthood
Albetawi, S. N., Meakin, A. S., Wiese, M. D., & Morrison, J. L. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.109729
Moustakli, E., Zikopoulos, A., Paraschos, V.-S., Katopodi, A. T., Arkoulis, I., Topis, S., Anagnostaki, I., Kathopoulis, N., Potiris, A., Christopoulos, P., et al. (2026) · Biomedicines · doi:10.3390/biomedicines14112590
Zeng, Z., Mo, D., Xiao, T., Ma, W., Sun, H., Gu, M., Huang, H., Leng, Y., Lin, M., Cui, S., et al. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.11.016
Gao, J., Zeng, R., Li, G., Liu, J., Xiong, A., Yao, C., Wang, J., & He, X. (2026) · Phytomedicine · doi:10.1016/j.phymed.2026.158920
Bao, X., Zhou, Y., Li, J., & Cui, S. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.119533
Metadata
- Authors
- Lockett, J., Inder, W. J., & Clifton, V. L.
- Affiliations
- Translational Research Institute (AU)
- The University of Queensland (AU)
- Corresponding author
- Clifton, Vicki L
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2024-03-29
- Volume
- 45
- Issue
- 4
- Pages
- 593-624
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC11244253
- OpenAlex
- W4393311343
- Semantic Scholar
- a78fd7ee02795bc5e44697be48249817e1804f01
- Cited by
- 135
- References
- 437
- Citations by year
- 2026: 75 · 2025: 51 · 2024: 9
- FWCI
- 9.29
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Endocrine Reviews (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- The University of Queensland Graduate School Scholarship
- Mater Research Institute Frank Clair Scholarship
- Metro South Health Research Support Scheme Project Grants
- National Health and Medical Research Council Senior Research Fellowship (APP1136100)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Keywords
- glucocorticoid receptor, receptor isoforms, glucocorticoid sensitivity, glucocorticoid resistance, transrepression, transcriptional activation, anti-inflammatory activity, metabolic effects, glucocorticoid adverse effects, receptor structure and function
- MeSH terms
- Animals, Glucocorticoids, Humans, Receptors, Glucocorticoid, Protein Isoforms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.